- cafead   Sep 13, 2024 at 11:13: AM
via Moderna’s mRNA cancer vaccine for solid tumours shows early signs of promise in interim data from a Phase I study.
The messenger ribonucleic acid (mRNA) specialist announced the vaccine has shown early signs of an immune response against cancer, with the shot triggering cancer-killing cells.
article source
The messenger ribonucleic acid (mRNA) specialist announced the vaccine has shown early signs of an immune response against cancer, with the shot triggering cancer-killing cells.
article source